Day: September 2, 2022

Big River shareholders vote in favour of acquisition by Aura

Written by Customer Service on September 2, 2022. Posted in Mergers And Acquisitions.

ROAD TOWN, British Virgin Islands, Sept. 02, 2022 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX:ORA, B3:AURA33) (“Aura” or the “Company”) is pleased to inform that Big River Gold Limited (ASX:BRV) (“Big River”) announced today in a Press Release that the requisite majorities of each class of shareholders voted in favour of the proposed scheme of arrangement (“Scheme”), pursuant to which Borborema LLC, an indirect wholly-owned subsidiary of Aura (“BidCo”) will acquire all of the shares in Big River (other than the shares held by Dundee Resources). As previously disclosed, Aura will hold its interest in BidCo through an intermediate holding company (“JVCo”) with Dundee Resources which agreed, subject to certain limited conditions, to receive shares in JVCo, in lieu of the cash consideration, in order to indirectly maintain an equity...

Benitec Biopharma Releases Full Year 2022 Financial Results and Provides Operational Update

Written by Customer Service on September 2, 2022. Posted in Earnings Releases And Operating Results.

HAYWARD, Calif., Sept. 02, 2022 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “the Company”), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed RNA interference (“ddRNAi”) platform, today announced financial results for its Fiscal Year ended June 30, 2022. The Company has filed its annual report on Form 10-K for the quarter ended June 30, 2022, with the U.S. Securities and Exchange Commission. “We continue to move closer to the initiation of the clinical evaluation of BB-301,” said Jerel A. Banks, M.D., Ph.D., Executive Chairman and Chief Executive Officer of Benitec Biopharma. “The Benitec team remains committed to improving the lives of patients suffering from Oculopharyngeal Muscular Dystrophy.” Operational...

Hurco Reports Third Quarter Results for Fiscal 2022

Written by Customer Service on September 2, 2022. Posted in Earnings Releases And Operating Results.

INDIANAPOLIS, Sept. 02, 2022 (GLOBE NEWSWIRE) — Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the third fiscal quarter ended July 31, 2022. Hurco recorded net income of $1,238,000, or $0.18 per diluted share, for the third quarter of fiscal 2022, compared to net income of $1,568,000, or $0.23 per diluted share, for the corresponding period in fiscal 2021. For the nine months of fiscal 2022, Hurco reported net income of $6,802,000, or $1.01 per diluted share, compared to net income of $4,668,000, or $0.70 per diluted share, for the corresponding period in fiscal 2021. Sales and service fees for the third quarter of fiscal 2022 were $57,640,000, an increase of $3,462,000, or 6%, compared to the corresponding prior year period, and included an unfavorable currency impact of $4,273,000, or 8%, when translating foreign...

SLR Investment Corp. Announces Monthly Distribution for September 2022

Written by Customer Service on September 2, 2022. Posted in Dividend Reports And Estimates.

NEW YORK, Sept. 02, 2022 (GLOBE NEWSWIRE) — SLR Investment Corp. (the “Company”) (NASDAQ: SLRC), today declared a distribution of $0.136667 per share for the month of September 2022. The distribution is payable on October 4, 2022 to stockholders of record as of September 20, 2022. The specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year. ABOUT SLR INVESTMENT CORP. SLR Investment Corp. is a closed-end investment company that has elected to be treated as a business development company under the Investment Company Act of 1940. A specialty finance company with expertise in several niche markets, the Company generally invests directly and indirectly in leveraged, U. S. middle market companies primarily in the form of cash flow senior secured loans, including...

Navient President and CEO to present at Barclays 2022 Global Financial Services Conference on Sept. 13

Written by Customer Service on September 2, 2022. Posted in Public Companies.

WILMINGTON, Del., Sept. 02, 2022 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI), a leader in technology-enabled education finance and business processing solutions, today announced that President and CEO Jack Remondi will participate in a fireside chat at the Barclays 2022 Global Financial Services Conference on Tuesday, Sept. 13. Remondi will deliver remarks at 12:00 p.m. ET. The webcast, along with any written materials or slides used during the presentation, will be available at Navient.com/investors. A replay will be available approximately two hours following the presentation through Sept. 27. About NavientNavient (Nasdaq: NAVI) provides technology-enabled education finance and business processing solutions that simplify complex programs and help millions of people achieve success. Our customer-focused, data-driven services deliver...

Wayne Bank Ranks in Top 100 Performing Banks in U.S.

Written by Customer Service on September 2, 2022. Posted in Public Companies.

HONESDALE, Pa., Sept. 02, 2022 (GLOBE NEWSWIRE) — Wayne Bank, a subsidiary of Norwood Financial Corp (Nasdaq Global Market – NWFL), was recently ranked as one of the top 100 performing banks in the country by Bank Director magazine. Coming in at number seventy-one, Wayne Bank was evaluated on its profitability, capital adequacy, asset quality, and total shareholder return within the $1 Billion to $5 Billion asset size level. President and Chief Executive Officer of Wayne Bank, James O. Donnelly, commented, “It is an honor to be included in this prestigious list of financial institutions. As a 150-year old community bank, Wayne Bank is committed to creating shareholder value by investing in our employees, customers, and communities, and we will continue to operate with that philosophy as we grow.” Bank Director has analyzed the...

Immuneering Announces Submission of IND Application to the FDA for Phase 1/2a Trial of IMM-1-104 to Treat Advanced Solid Tumors with RAS Mutations

Written by Customer Service on September 2, 2022. Posted in Public Companies.

CAMBRIDGE, Mass., Sept. 02, 2022 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company using translational bioinformatics to advance a pipeline of product candidates designed to benefit large populations of patients with cancer and other diseases, today announced it submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA). The IND application supports a Phase 1/2a clinical trial of IMM-1-104, an oral once daily small molecule in development for the treatment of advanced RAS mutant solid tumors. In contrast to the narrow approach of targeting specific mutations such as KRAS-G12C, IMM-1-104 is a third generation MEK inhibitor designed for broad pan-RAS activity as well as activity in other MAPK-activated tumors. Based on preclinical data to date, IMM-1-104...

Smaller Related Party Transaction

Written by Customer Service on September 2, 2022. Posted in Public Companies.

HARGREAVE HALE AIM VCT PLC LEI: 213800LRYA19A69SIT3 2 September 2022 Smaller Related Party Transaction Hargreave Hale AIM VCT plc (the “Company“) announces that, following a review of board remuneration and taking into account peer group analysis and inflation, the Board has decided to increase each Director’s annual remuneration with effect from 1 October 2022. The annual remuneration of the Chairman will increase to £39,000, the independent non-executive directors to £30,500 and the non-independent non-executive director, Oliver Bedford, to £28,000. An additional fee of £1,500 will continue to be paid to the Chairman of the Management and Service Provider Engagement Committee and the Chairman of the Audit Committee will continue to receive an additional fee of £3,000. The fee payable to Oliver Bedford is paid directly...

Nocopi Technologies Completes 1-for-10 Reverse Stock Split Effective Today

Written by Customer Service on September 2, 2022. Posted in Public Companies.

KING OF PRUSSIA, Pa., Sept. 02, 2022 (GLOBE NEWSWIRE) — Nocopi Technologies, Inc. (OTC Pink: NNUP), a developer of specialty reactive inks, today announced that the one-for-ten (1:10) reverse stock split of the Company’s common stock is effective as of September 2, 2022 (the “Effective Date”). Nocopi’s SEC filings are available here. Pursuant to the reverse stock split, Nocopi stockholders received one (1) new share of common stock for every ten (10) shares held prior to the Effective Date. Any fractional shares were rounded up to the next whole share. Nocopi’s common stock is now trading with a “D” added to the symbol or “NNUPD” to designate that it is trading on a post reverse stock split basis and will resume trading under the symbol “NNUP” after a 20-trading day period has expired. The reverse stock...

Form 8.3 – [CareTech Holdings plc – 01 09 2022] – (CGWL)

Written by Customer Service on September 2, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree CARETECH HOLDINGS PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position...

Day: September 2, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals